Table 2 Basic information for younger patients 2020
Study group (n) | Gender (M/F) | Age (years) | Presence or absence of chronic underlying disease (yes/no) | First NLR | Length of stay (days) | Outcome (death/survival) | Duration of infection (days) | Blood sampling period |
|---|---|---|---|---|---|---|---|---|
Patients with asymptomatic OMICRON infection (n = 281) | 167/114 | 22.40 ± 12.87 | No | 3.13 ± 2.47 | 15.47 ± 6.82 | Survival | 13.42 ± 6.82 | April 1–April 15, 2020 |
Patients with mild COVID-19 infection in 2020 (n = 54) | 31/23 | 40.45 ± 15.34 | No | 3.56 ± 1.93 | 20.61 ± 7.80 | Survival | 17.61 ± 7.80 | April 1–April 14, 2022 |
X2/t value | 0.077 | − 9.1 | – | − 1.002 | -4.894 | – | − 3.946 | – |
P value | 0.782 | < 0.001 | – | 0.317 | < 0.001 | – | < 0.001 | – |